Nine bidders shortlisted for redevelopment of Mumbai's iconic CSMT station-March 2024-www.financetom.com

Nine bidders shortlisted for redevelopment of Mumbai's iconic CSMT station

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nine bidders shortlisted for redevelopment of Mumbai's iconic CSMT station

Jun 1, 2021 1:56 PM

Mumbai's iconic Chhatrapati Shivaji Maharaj Terminus is all set for a makeover.

The Indian Railway Stations Development Corporation (IRSDC) has shortlisted 9 bidders for the redevelopment work.

Anu Sharma reports that the project cost is about Rs 1640 crore and the shortlisted bidders include marquee names like Godrej Properties, Kalpataru Power, Oberoi Realty, GMR Enterprises, Adani Railways Transport among others.

Watch video to know more.

(Edited by : Aditi Gautam)

Previous page： Boston Scientific Says Japan Approved Farapulse Pulsed Field Ablation System Next page： Sanofi, Regeneron Pharmaceuticals Receive Chinese Regulator's Approval for Dupixent as Chronic Obstructive Pulmonary Disease Treatment

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boston Scientific Says Japan Approved Farapulse Pulsed Field Ablation System

Oct 2, 2024

07:35 AM EDT, 09/27/2024 (MT Newswires) -- Boston Scientific ( BSX ) said Friday it has received approval for its Farapulse pulsed field ablation system from Japan's Pharmaceuticals and Medical Device Agency. The Farapulse system is indicated to isolate pulmonary veins to treat paroxysmal atrial fibrillation, the company added. The system uses non-thermal electrical fields to ablate cardiac tissue associated...

Sanofi, Regeneron Pharmaceuticals Receive Chinese Regulator's Approval for Dupixent as Chronic Obstructive Pulmonary Disease Treatment

Oct 2, 2024

07:38 AM EDT, 09/27/2024 (MT Newswires) -- Sanofi ( SNY ) and Regeneron Pharmaceuticals ( REGN ) said Friday that China's National Medical Products Administration has approved Dupixent as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, or COPD, characterized by raised blood eosinophils. The companies said the approval particularly covers patients who are under treatment...

Top Premarket Gainers

Oct 2, 2024

07:32 AM EDT, 09/27/2024 (MT Newswires) -- Onconetix ( ONCO ) shares soared 80% pre-bell Friday following a 3% loss in the previous session. Establishment Labs ( ESTA ) shares rose 27% after the company secured US Food and Drug Administration approval for Motiva breast implants. NaaS Technology ( NAAS ) shares increased 12%, extending gains from the previous session....

BMO on The Day Ahead in Canada

Oct 2, 2024

07:35 AM EDT, 09/27/2024 (MT Newswires) -- Canada's gross domestic product data for July and flash August at 8:30 a.m. ET Friday could have a major bearing on the size of the next rate cut by the country's central bank, said Bank of Montreal (BMO). Real GDP numbers for July and flash August will guide estimates for the quarter, noted...